Harvard Bioscience Inc (HBIO): Next-Year EPS Estimate 97.05%
As of 2026-11-12, Harvard Bioscience Inc (HBIO) has a next-year EPS growth estimate of 97.05%. Featured in our EPS revision report on 2026-08-20.
On 2026-11-11, analyst consensus for HBIO's next-year EPS growth shifted from 103.95% to 97.05% — a negative change of 6.90 percentage points. The revised estimate has been sustained across 2 subsequent trading sessions. Current-year growth is projected at -408.33%.
What's Driving This
The only EPS revision in the data is downward, not an upgrade: on 2026-11-11 analysts lowered next-year EPS growth estimates from 103.95% to
Generated 2026-11-12 from news as of 2026-11-12
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- EPS growth next year
- 97.05%
- EPS growth this year
- -408.33%
- EPS next quarter (est)
- $0.00
- Last price
- $9.22
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-11-12 | 97.05% | -408.33% | $0.00 | $9.22 |
| 2026-11-11 | 97.05% | -408.33% | $0.00 | $9.68 |
| 2026-11-10 | 103.95% | -448.33% | $0.02 | $9.26 |
| 2026-11-09 | 104.38% | -433.33% | -$0.33 | $9.09 |
| 2026-11-07 | 104.38% | -433.33% | -$0.33 | $8.36 |
| 2026-11-06 | 104.38% | -433.33% | -$0.33 | $8.36 |
| 2026-11-05 | 104.38% | -433.33% | -$0.33 | $8.46 |
| 2026-11-04 | 104.38% | -433.33% | -$0.33 | $8.61 |
| 2026-11-03 | 104.38% | -433.33% | -$0.33 | $8.67 |
| 2026-11-02 | 104.38% | -433.33% | -$0.33 | $8.60 |
| 2026-10-31 | 269.74% | -90.00% | -$0.17 | $8.90 |
| 2026-10-30 | 269.74% | -90.00% | -$0.17 | $8.90 |
| 2026-10-29 | 269.74% | -90.00% | -$0.17 | $8.80 |
| 2026-10-28 | 269.74% | -90.00% | -$0.17 | $8.42 |
| 2026-10-27 | 269.74% | -90.00% | -$0.17 | $8.35 |
| 2026-10-26 | 269.74% | -90.00% | -$0.17 | $8.32 |
| 2026-10-23 | 269.74% | -90.00% | -$0.17 | $8.23 |
| 2026-10-22 | 269.74% | -90.00% | -$0.17 | $8.34 |
| 2026-10-21 | 269.74% | -90.00% | -$0.17 | $8.49 |
| 2026-10-20 | 269.74% | -90.00% | -$0.17 | $8.34 |
| 2026-10-19 | 269.74% | -90.00% | -$0.17 | $8.09 |
| 2026-10-16 | 269.74% | -90.00% | -$0.17 | $8.09 |
| 2026-10-15 | 269.74% | -90.00% | -$0.17 | $8.31 |
| 2026-10-14 | 269.74% | -90.00% | -$0.17 | $8.15 |
| 2026-10-13 | 269.74% | -90.00% | -$0.17 | $8.27 |
| 2026-10-12 | 269.74% | -90.00% | -$0.17 | $8.24 |
| 2026-10-11 | 269.74% | -90.00% | -$0.17 | $8.24 |
| 2026-10-10 | 269.74% | -90.00% | -$0.17 | $8.24 |
| 2026-10-09 | 269.74% | -90.00% | -$0.17 | $8.24 |
| 2026-10-08 | 269.74% | -90.00% | -$0.17 | $8.13 |
Reports Featuring HBIO
Recent News
- Harvard Bioscience, Inc. Q2 2026 Earnings Call SummaryMoby
- Harvard Bioscience, Inc. Q2 2026 Earnings Call SummaryMoby
- Harvard Bioscience Inc (HBIO) (Q2 2026) Earnings Call Highlights: Revenue Surges 11% and ...GuruFocus.com
- Harvard Bioscience Inc (HBIO) (Q2 2026) Earnings Call Highlights: Revenue Surges 11% and ...GuruFocus.com
- Harvard Bioscience beats Q2 estimates and raises 2026 revenue guidanceInvestorsHub
- Harvard Bioscience: Q2 Earnings SnapshotAssociated Press
- Harvard Bioscience Announces Second Quarter 2026 Financial ResultsGlobeNewswire
Screen Performance
Aggregate stats across all 2145 tickers our top-EPS-revision screen has flagged over the past 225 days.
- Median return since detection
- -2.9%
- % of tickers in the green
- 43%
- Median return on winners
- +22.8%
- Large revisions captured
- 2246
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Harvard Bioscience Inc's next-year EPS growth estimate?▾
As of 2026-11-12, Harvard Bioscience Inc (HBIO) has a next-year EPS growth estimate of 97.05%, based on analyst consensus.
When was the latest EPS estimate revision for HBIO?▾
The most recent revision occurred on 2026-11-11, when analysts adjusted the next-year EPS growth estimate from 103.95% to 97.05%.
What sector and industry does Harvard Bioscience Inc belong to?▾
Harvard Bioscience Inc operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. HBIO appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Harvard Bioscience Inc (HBIO) appears here because it was detected by our daily top-EPS-revision-performer screen.